Biosensors and Nanotheranostics
Bionanotechnology, Drug Delivery, Therapeutics | online ISSN 3064-7789
  1. You are here:
  2. Home
  3. Journals
  4. Biological Sciences
RESEARCH ARTICLE   (Open Access)
Contents Vol 3 (1)

Novel Hesperidin-Loaded Silver Nanoparticles for Targeted Cancer Drug Delivery

Sneha Salian 1, Anoop Narayanan V 1*

+ Author Affiliations

Biosensors and Nanotheranostics 3 (1) 1-8 https://doi.org/10.25163/biosensors.3173410

Submitted: 15 March 2024 Revised: 26 April 2024  Published: 01 May 2024 

Abstract

Background: Silver nanoparticles (SNPs) are increasingly recognized for their chemical stability, biocompatibility, antimicrobial properties, and intrinsic therapeutic activity. Hesperidin, a secondary metabolite found primarily in citrus fruits, is known for its potent antioxidant and anticancer properties. Loading hesperidin onto the surface of silver nanoparticles may enhance its biological activity by improving cellular penetration and enabling targeted delivery. This study aimed to formulate hesperidin-loaded silver nanoparticles and evaluate their anticancer potential. Methods: Hesperidin-loaded silver nanoparticles were formulated by reacting 1 mg of hesperidin dissolved in 10 mL of methanol with 90 mL of 1 mM silver nitrate solution, adjusted to a pH of 10. The formation of nanoparticles was confirmed by a peak at 419 nm in the UV-Visible spectra. Plain silver nanoparticles were also synthesized for comparison using trisodium citrate as a reducing agent. The formulations were characterized using Fourier Transform Infrared Spectroscopy (FTIR) to confirm the loading of hesperidin on the metal surface through the identification of corresponding functional groups. Particle size and zeta potential were measured to assess the stability and size distribution of the nanoparticles. Additionally, antioxidant activity was evaluated, and an anticancer study was performed on lung cancer cell lines to compare the cytotoxic effects of hesperidin and hesperidin-loaded silver nanoparticles. Results: The particle size of the hesperidin-loaded silver nanoparticles was found to be 96.61 ± 2.39 nm with a polydispersity index (PDI) of 0.368 ± 0.02, and a zeta potential of -19.9 ± 0.6 mV. In comparison, plain silver nanoparticles had a particle size of 95.68 ± 17.87 nm, a PDI of 0.51 ± 0.12, and a zeta potential of -27.1 ± 1.21 mV. The antioxidant activity of the hesperidin-loaded silver nanoparticles was higher compared to plain hesperidin. However, the anticancer study revealed that hesperidin alone induced higher cytotoxicity than the hesperidin-loaded silver nanoparticles on lung cancer cell lines. Conclusion: The loading of hesperidin onto silver nanoparticles enhances its antioxidant potential, suggesting a potential for targeted delivery and therapeutic applications. Despite the reduced cytotoxicity of hesperidin-loaded silver nanoparticles compared to hesperidin alone in lung cancer cell lines, further studies are warranted to explore their potential for targeted anticancer therapies.

Keywords: Hesperidin-loaded silver nanoparticles (HLSNPs), Targeted drug delivery, Cancer therapy, Green synthesis, Anticancer properties

References

Banu, A., Gousuddin, M., & Yahya, E. B. (2021). Green synthesized monodispersed silver nanoparticles’ characterization and their efficacy against cancer cells. Biomedical Research and Therapy, 8, 4476–4482. https://doi.org/10.15419/bmrat.v8i8.686

Bhakat, C. (2012). Effects of silver nanoparticles synthesize from Ficus benjamina on normal cells and cancer cells. IOSR Journal of Pharmacy and Biological Sciences, 1, 33–36. https://doi.org/10.9790/3008-0143336

Birsu Cincin, Z., Unlu, M., Kiran, B., Sinem Bireller, E., Baran, Y., & Cakmakoglu, B. (2015). Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells. Cellular Oncology (Dordrecht, Netherlands), 38, 195–204. https://doi.org/10.1007/s13402-015-0222-z

Chang, D., Ma, Y., Xu, X., Xie, J., & Ju, S. (2021). Stimuli-responsive polymeric nanoplatforms for cancer therapy. Frontiers in Bioengineering and Biotechnology, 9, 707319. https://doi.org/10.3389/fbioe.2021.707319

Faisal, S., Hamed, A. A., Shawky, R. M., & Emara, M. (2023). Chitosan-silver nanoparticles: A versatile conjugate for biotechnological advancements. Journal of Advanced Pharmacy Research, 7, 163–169. https://doi.org/10.21608/aprh.2023.218891.1222

Garcia-Bennett, A., Nees, M., & Fadeel, B. (2011). In search of the holy grail: Folate-targeted nanoparticles for cancer therapy. Biochemical Pharmacology, 81, 976–984. https://doi.org/10.1016/j.bcp.2011.01.023

Gregoriou, Y., Gregoriou, G., Manoli, A., Papageorgis, P., Mc Larney, B., Vangeli, D., McColman, S., Yilmaz, V., Hsu, H. T., Skubal, M., & et al. (2023). Photophysical and biological assessment of Coumarin-6 loaded polymeric nanoparticles as a cancer imaging agent. Sensors & Diagnostics, 2, 1277–1285. https://doi.org/10.1039/D3SD00065F

J, B. (2024). Characterization and evaluation of green synthesized silver nanoparticles using Moringa oleifera leaf extract and its antihypertensive activity. Annals of Clinical and Medical Case Reports, 13, 01–09. https://doi.org/10.47829/acmcr.2024.131602

Jeong, S. A., Yang, C., Song, J., Song, G., Jeong, W., & Lim, W. (2022). Hesperidin suppresses the proliferation of prostate cancer cells by inducing oxidative stress and disrupting Ca2+ homeostasis. Antioxidants (Basel), 11. https://doi.org/10.3390/antiox11091633

Kong, W., Ling, X., Chen, Y., Wu, X., Yao, W., Chen, X., & Zeng, Y. (2021). Hesperidin inhibits growth and angiogenesis of glioma. Frontiers in Pharmacology, 12, 733491. https://doi.org/10.3389/fphar.2021.733491

Kumar, S., Kumar, D., Sahu, M., & Kumar, A. (2020). Pharmacological and nanobiotechnological aspects of Gymnema Sylvestre. International Journal of Advanced Research (Indore), 8, 901–913. https://doi.org/10.21474/ijar01/11916

Lade, B. D., & Shanware, A. (2020). Phytonanofabrication: Methodology and factors affecting biosynthesis of nanoparticles. IntechOpen. https://doi.org/10.5772/intechopen.90918

Leau, S. A., Marin, S., Coara, G., Albu, L., Constantinescu, R. R., Kaya, M. A., & Neacsu, I. A. (2018). Study of wound-dressing materials based on collagen, sodium carboxymethylcellulose and silver nanoparticles used for their antibacterial activity in burn injuries. ICAMS Proceedings of the International Conference on Advanced Materials and Systems, 123–128. https://doi.org/10.24264/icams-2018.i.18

Liang, Z., Song, J., Xu, Y., Zhang, X., Zhang, Y., & Qian, H. (2022). Hesperidin reversed long-term N-methyl-N-nitro-N-nitroguanidine exposure induced EMT and cell proliferation by activating autophagy in gastric tissues of rats. Nutrients, 14. https://doi.org/10.3390/nu14245281

Nikolopoulou, S. G., Kalska, B., Basa, A., Papadopoulou, A., & Efthimiadou, E. K. (2023). Novel hybrid silver-silica nanoparticles synthesized by modifications of the sol-gel method and their theranostic potential in cancer. ACS Applied Bio Materials, 6, 5235–5251. https://doi.org/10.1021/acsabm.3c00494

Poomipark, N., Chaisin, T., & Kaulpiboon, J. (2023). Anti-proliferative, anti-migration, and anti-invasion activity of novel hesperidin glycosides in non-small cell lung cancer A549 cells. Research in Pharmaceutical Sciences, 18, 478. https://doi.org/10.4103/1735-5362.383704

Potara, M., Baia, M., Farcau, C., & Astilean, S. (2012). Chitosan-coated anisotropic silver nanoparticles as a SERS substrate for single-molecule detection. Nanotechnology, 23, 055501. https://doi.org/10.1088/0957-4484/23/5/055501

Rizvi, S. A. A., & Saleh, A. M. (2018). Applications of nanoparticle systems in drug delivery technology. Saudi Pharmaceutical Journal, 26, 64–70. https://doi.org/10.1016/j.jsps.2017.10.012

Rusdin, M., & Indonesian Journal of Pharmaceutics. (n.d.). Nanoparticles targeted drug delivery system via epidermal growth factor receptor: A review. Indonesian Journal of Pharmaceutics. Retrieved September 1, 2024, from https://jurnal.unpad.ac.id/idjp/article/view/23613

Tan, S., Dai, L., Tan, P., Liu, W., Mu, Y., Wang, J., Huang, X., & Hou, A. (2020). Hesperidin administration suppresses the proliferation of lung cancer cells by promoting apoptosis via targeting the MiR-132/ZEB2 signalling pathway. International Journal of Molecular Medicine, 46, 2069–2077. https://doi.org/10.3892/ijmm.2020.4756

TR, A., Selvaraju, K., & Gowrishankar, N. (2023). Biodegradable polymeric nanoparticles: The novel carrier for controlled release drug delivery system. International Journal of Science and Research Archive, 8, 630–637. https://doi.org/10.30574/ijsra.2023.8.1.0103

Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012). Nanoparticle delivery of cancer drugs. Annual Review of Medicine, 63, 185–198. https://doi.org/10.1146/annurev-med-040210-162544

Wudtiwai, B., Makeudom, A., Krisanaprakornkit, S., Pothacharoen, P., & Kongtawelert, P. (2021). Anticancer activities of hesperidin via suppression of up-regulated programmed death-ligand 1 expression in oral cancer cells. Molecules, 26. https://doi.org/10.3390/molecules26175345

Yao, Y., Lin, M., Liu, Z., Liu, M., Zhang, S., & Zhang, Y. (2022). Hesperidin inhibits lung cancer in vitro and in vivo through PinX1. Frontiers in Pharmacology, 13, 918665. https://doi.org/10.3389/fphar.2022.918665

Zhao, J., Li, Y., Gao, J., & De, Y. (2017). Hesperidin inhibits ovarian cancer cell viability through endoplasmic reticulum stress signaling pathways. Oncology Letters, 14, 5569–5574. https://doi.org/10.3892/ol.2017.687

PDF
Abstract
Export Citation

View Dimensions


View Plumx


View Altmetric




Save
0
Citation
243
View

Share